SOP 22.044
TRANSPORTATION OF GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS For Password contact Lead Pharmacist Clinical Trials R&I
Home > Staff & Recruitment > Staff Resources & Support >
Staff Resources & Support
SOP 22.043
ENVIRONMENTAL MONITORING OF THE ISOLATOR AND ROOM USED TO PREPARE GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS For Password contact Lead Pharmacist Clinical Trials R&I
SOP 22.042
PERSONAL PROTECTIVE EQUIPMENT (PPE) TO BE WORN WHEN HANDLING GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS For Password contact Lead Pharmacist Clinical Trials R&I
SOP 22.041
ASEPTIC PREPARATION OF GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS For Password contact Lead Pharmacist Clinical Trials R&I
SOP 22.040
SAFE HANDLING OF SPILLAGE, PERSONAL CONTAMINATION OR INJURY INVOLVING GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS For Password contact Lead Pharmacist Clinical Trials R&I
Schedule of Accreditation
UKAS Schedule of Accreditation
Uncertainty of Measurement Summary Table for Specialist Techniques
For acetylcholine receptor antibodies, GAD antibodies (for diabetes and Stiff Persons’ Syndrome), intrinsic factor antibodies and functional antibodies.
Uncertainty of Measurement Summary Table for Optilite analyser
For C1 inhibitor quantitative assay and serum free light chains.
IA2 and ZnT8 antibody results delay – update
Further information on the delay in release of IA2 and ZnT8 antibody results is provided below, alongside guidance for their interpretation.